| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.64 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |